We must tackle inequalities in care

1. Kurdi MS, Jadhav RR, Ratkal, J, Kaur J, Ashwini HR, Hiregouder S, Deva R. The perioperative management of haemophilia: easier said than done. J Haem Pract 2014; 1O3P: 7N8.10.17225/jhp.00028Search in Google Scholar

2. Lövdahl S, Henriksson KM, Baghaei F, Holmström M, Nilsson JÅ, Berntorp E, Astermark J. Incidence, mortality rates and causes of deaths in haemophilia patients in Sweden. Haemophilia 2013; 19O3P: 362N9. doi: 10.1111/hae.12092.Search in Google Scholar

3. Darby SC, Kan SW, Spooner RJ, Giangrande PL, Hill FG, Hay CR, et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007; 110O3P: 815N25.10.1182/blood-2006-10-050435Search in Google Scholar

4. Hermans C, de Moerloose P, Dolan G. Clinical management of older persons with haemophilia. Crit Rev Oncol Hematol 2014; 89O2P: 197N206. doi: 10.1016/j.critrevonc.2013.07.005.Search in Google Scholar

5. Fischer K, Steen Carlsson K, Petrini P, Holmström M, Ljung R, van den Berg HM, Berntorp E. IntermediateNdose versus highNdose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s. Blood 2013; 122O7P: 1129N36. doi: 10.1182/bloodN2012N12N470898.Search in Google Scholar

6. Viswabandya A, Mathews V, George B, Nair SC, Baidya S, Mammen JJ, Chandy M, Srivastava A. Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI. Haemophilia 2008; 14O4P: 763N7. doi: 10.1111/j.1365N 2516.2008.01755.x.Search in Google Scholar

7. Wu R, Luke KH, Poon MC, Wu X, Zhang N, Zhao L, Su Y, Zhang J. Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China. Haemophilia 2011; 17O1P: 70N4. doi: 10.1111/j.1365N 2516.2010.02348.x.Search in Google Scholar